AI Multi-Triage Solution Earns FDA Breakthrough Designation
The designation will expedite the review process for the CT-based artificial intelligence, which flags numerous acute conditions simultaneously.
The designation will expedite the review process for the CT-based artificial intelligence, which flags numerous acute conditions simultaneously.
Innoblative's SIRA RFA Electrosurgical Device is intended for use in breast cancer patients undergoing BCS.
The Stimdia pdSTIM system is designed to facilitate weaning patients from mechanical ventilation by reconditioning the diaphragm.
The designation will expedite the review process for the CT-based artificial intelligence, which flags numerous acute conditions simultaneously.